Selected Quarterly Financial Information (Tables)

12 Months Ended

Dec. 31, 2016

Selected Quarterly Financial Information [Abstract]

Schedule Of Quarterly Financial Information

	First			Second			Third			Fourth
	Quarter			Quarter			Quarter			Quarter
REVENUE:
2016	$	43,016	*	$	47,083	*	$	45,252	*	$	45,029	*
2015		33,831			35,526			36,703			39,838
2014		35,731			34,690			37,069			37,151
GROSS MARGIN:
2016	$	27,621	*	$	30,301	*	$	29,782	*	$	31,195	*
2015		19,667			21,554			22,982			26,516
2014		22,473			22,384			23,799			22,635
NET INCOME (LOSS):
2016	$	2,541	*	$	2,347	*	$	2,993	*	$	2,897	*
2015		(274)			(502)			2,145			2,636
2014		1,059			2,161			2,326			1,776
INCOME (LOSS) PER COMMON SHARE—DILUTED:
2016	$	0.08	*	$	0.07	*	$	0.09	*	$	0.09	*
2015		(0.01)			(0.02)			0.07			0.09
2014		0.04			0.08			0.08			0.06

*In January 2016 the Company completed its acquisition of On-X Life Technologies Holdings, Inc., which is being operated as a wholly owned subsidiary of CryoLife.  In 2016 the Company also sold its HeRO Graft product line and its ProCol product line, and ceased sales of these products during 2016.